☰

Nicolas Gestermann

Affiliations: 
University Paris 11 
Area:
Sjögren’s syndrome, IRF5, Methylation, STAT4, Type I interferon, Genetic, Epigenetic, IL-12, CD4+ T cells, Plasmacytoid dendritic cells
Google:
"Nicolas Gestermann"
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Xavier Mariette grad student 2012 University Paris 11
 (Causes et conséquences de l’activation de l’interféron de type I dans les maladies auto-immunes. Étude dans le modèle du syndrome de Sjögren)
Corinne Miceli-Richard grad student 2012 University Paris 11
 (Causes et conséquences de l’activation de l’interféron de type I dans les maladies auto-immunes. Étude dans le modèle du syndrome de Sjögren)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Belkhir R, Gestermann N, Koutero M, et al. (2014) Upregulation of membrane-bound CD40L on CD4+ T cells in women with primary Sjögren's syndrome. Scandinavian Journal of Immunology. 79: 37-42
Gestermann N, Koutero M, Belkhir R, et al. (2012) Methylation profile of the promoter region of IRF5 in primary Sjögren's syndrome. European Cytokine Network. 23: 166-72
Mekinian A, Tamouza R, Pavy S, et al. (2011) Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis. European Cytokine Network. 22: 88-102
Gestermann N, Mekinian A, Comets E, et al. (2010) STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling. Genes and Immunity. 11: 432-8
Gestermann N, Mekinian A, Comets E, et al. (2010) Erratum: STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling Genes & Immunity. 11: 446-446
Miceli-Richard C, Gestermann N, Ittah M, et al. (2009) The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome. Arthritis and Rheumatism. 60: 1991-7
Miceli-Richard C, Gestermann N, Amiel C, et al. (2009) Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies. Arthritis Research & Therapy. 11: R77
Sellam J, Miceli-Richard C, Gottenberg JE, et al. (2007) Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Annals of the Rheumatic Diseases. 66: 790-7
Sellam J, Miceli-Richard C, Gottenberg J, et al. (2006) Expression du récepteur de BAFF (B cell Activator Factor of TNF Family), BAFF-R, au cours du syndrome de Sjögren primitif et du lupus systémique Revue Du Rhumatisme. 73: 1200
See more...